Sam-Yellowe T Y, Ndengele M M
Department of Biology, Cleveland State University, Ohio 44115-2403.
Exp Parasitol. 1993 Feb;76(1):46-58. doi: 10.1006/expr.1993.1006.
Plasmodium falciparum rhoptry proteins of the 140/130/110-kDa high molecular weight complex (HMWC) are secreted into the erythrocyte membrane during merozoite invasion. Epitopes of membrane-associated HMWC proteins can be detected using rhoptry-specific antibodies by immunofluorescence assays. Phospholipase treatment of ring-infected intact human erythrocytes, membrane ghosts, and inside-out vesicles results in the release of the HMWC as demonstrated by immunoblotting. We characterized the membrane-associating properties of the 110-kDa protein in more detail. PLA2 from three different sources; bee venom, Naja naja venom, and porcine pancreas, were examined and all were equally effective in releasing the 110-kDa protein. Furthermore, PLA2 activity was inhibited by o-phenanthroline, quinacrine, maleic anhydride, and partially by p-bromophenacyl bromide, indicating that the activity of PLA2 is specific. Using sequential protease and phospholipase digestion experiments to map the immunoreactive and functional epitopes of the 110-kDa protein, a 35-kDa protease-resistant protein associated with mouse and human erythrocyte membranes was identified. Limited proteolysis of the 110-kDa protein and analysis by immunoblotting demonstrated several immunoreactive cleavage products, including a highly protease-resistant peptide fragment of approximately 35-kDa which corresponds to the membrane-associated protein. Epitope mapping of the 130-kDa rhoptry protein resulted in a different pattern of cleavage products. Stage-specific metabolic labeling of P. falciparum with [3H] palmitate and [3H] myristate was performed to determine the lipophilic properties of the HMWC. Results showed the incorporation of label into proteins of approximate molecular weight 200 and 45-kDa, predominantly in the late schizont stage. Interestingly, proteins of 140 and 110/100-kDa, corresponding to [35S] methionine-labeled proteins were labeled with [3H]palmitate in ring-infected erythrocyte membranes. However, these proteins were not immunoprecipitated by a rhoptry protein-specific monoclonal antibody, 1B9. Similar label incorporation was not obtained with [3H]myristate. In Triton X-114 solubility studies, the HMWC proteins partitioned into the aqueous phase, suggesting that they are not integral membrane proteins. In addition, the proteins were extracted by 100 mM Na2CO3, pH 11.5, and immunoprecipitated by rhoptry-specific antibody. These results suggest that the HMWC proteins may exist in a soluble and membrane bound form. The latter may participate in membrane expansion and the formation of the parasitophorous vacuole during merozoite invasion.
恶性疟原虫140/130/110-kDa高分子量复合物(HMWC)的棒状体蛋白在裂殖子侵入期间分泌到红细胞膜中。使用棒状体特异性抗体通过免疫荧光测定法可检测膜相关HMWC蛋白的表位。用磷脂酶处理环状感染的完整人红细胞、膜空泡和外翻囊泡,免疫印迹证明HMWC会释放出来。我们更详细地描述了110-kDa蛋白的膜结合特性。检测了来自三种不同来源的磷脂酶A2;蜂毒、眼镜蛇毒和猪胰脏,它们在释放110-kDa蛋白方面同样有效。此外,邻菲啰啉、奎纳克林、马来酸酐以及部分对溴苯甲酰溴抑制了磷脂酶A2的活性,表明磷脂酶A2的活性具有特异性。通过连续的蛋白酶和磷脂酶消化实验来定位110-kDa蛋白的免疫反应性和功能性表位,鉴定出一种与小鼠和人红细胞膜相关的35-kDa蛋白酶抗性蛋白。对110-kDa蛋白进行有限的蛋白酶解并通过免疫印迹分析,显示出几种免疫反应性裂解产物,包括一个约35-kDa的高度蛋白酶抗性肽片段,它对应于膜相关蛋白。对130-kDa棒状体蛋白进行表位定位产生了不同的裂解产物模式。用[3H]棕榈酸酯和[3H]肉豆蔻酸酯对恶性疟原虫进行阶段特异性代谢标记,以确定HMWC的亲脂特性。结果显示标记掺入到分子量约为200和45-kDa的蛋白质中,主要在晚期裂殖体阶段。有趣的是,与[35S]甲硫氨酸标记的蛋白质相对应的140和110/100-kDa蛋白在环状感染的红细胞膜中被[3H]棕榈酸酯标记。然而,这些蛋白不能被棒状体蛋白特异性单克隆抗体1B9免疫沉淀。用[3H]肉豆蔻酸酯未获得类似的标记掺入。在Triton X-114溶解度研究中,HMWC蛋白分配到水相中,表明它们不是整合膜蛋白。此外,这些蛋白可被100 mM Na2CO3(pH 11.5)提取,并被棒状体特异性抗体免疫沉淀。这些结果表明HMWC蛋白可能以可溶性和膜结合形式存在。后者可能在裂殖子侵入期间参与膜扩张和寄生泡的形成。